Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
John Pierce, PhD, answers our questions about his team’s recent study that examined how youth e-cigarette use and other predictors impact the progression to later daily cigarette smoking.
John Pierce, PhD, answers our questions about his team’s recent study that examined how youth e-cigarette use and other predictors impact the progression to later daily cigarette smoking.
John Pierce, PhD, answers our questions about his team’s recent study that examined how youth e-cigarette use and other predictors impact the progression to later daily cigarette smoking.
John Pierce, PhD, answers our questions about his team’s recent study that examined how youth e-cigarette use and other predictors impact the progression to later daily cigarette smoking.
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
